Future Procurement Opportunity (Fpo) - Supply Of Transdermal Oestradiol Product(S)

Pharmaceutical Management Agency New Zealand has Released a tender for Future Procurement Opportunity (Fpo) - Supply Of Transdermal Oestradiol Product(S) in Healthcare and Medicine. The tender was released on Nov 23, 2023.

Country - New Zealand

Summary - Future Procurement Opportunity (Fpo) - Supply Of Transdermal Oestradiol Product(S)

Deadline - Feb 28, 2025

MT reference number - 74921964

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

  Address - New Zealand

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 74921964

  Document Type - Tender Notices

Notice Details and Documents:

Description - Details RFx ID: 27882850 Tender Name: Future Procurement Opportunity (FPO) - Supply of transdermal oestradiol product(s) Reference #: A1436422 Open Date: Q3 2023 Indicative RFx Release Date : Q1 2024[?] Tender Type: Future Procurement Opportunity (FP O) Project Status: Initial development[?] Indicative Total Value: $1M - $5M[?] Categories: 51000000 - Drugs and Pharmaceutical Products Regions: New Zealand Required Pre-qualifications: None Contact: Pharmac Procurement Team procurement@pharmac.govt.nz Overview Oestradiol is the major female sex hormone. It is used in the management of a range of conditions. We understand most of the funded oestradiol usage in New Zealand is for the management of

Mt Ref Id - 74921964

Deadline - Feb 28, 2025

Share

Similar Tenders :